These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

873 related items for PubMed ID: 18975519

  • 1. In vitro study to compare sensitivity of amoxicillin+clavulanic acid and cefpodoxime+clavulanic acid among beta-lactamase positive clinical isolates of gram-positive and gram-negative pathogens.
    Pal RB, Pal P, Jain S, Kulkarni KP.
    J Indian Med Assoc; 2008 Aug; 106(8):545-8. PubMed ID: 18975519
    [Abstract] [Full Text] [Related]

  • 2. In vitro evaluation of a new cefixime-clavulanic acid combination for gram-negative bacteria.
    Rawat D, Hasan AS, Capoor MR, Sarma S, Nair D, Deb M, Pillai P, Aggarwal P.
    Southeast Asian J Trop Med Public Health; 2009 Jan; 40(1):131-9. PubMed ID: 19323045
    [Abstract] [Full Text] [Related]

  • 3. Extended-spectrum beta-lactamase-mediated resistance among bacterial isolates recovered from ocular infections.
    Jayahar Bharathi M, Ramakrishnan R, Ramesh S, Murugan N.
    Ophthalmic Res; 2012 Jan; 47(1):52-6. PubMed ID: 21720185
    [Abstract] [Full Text] [Related]

  • 4. Evaluation of the MicroScan ESBL plus confirmation panel for detection of extended-spectrum beta-lactamases in clinical isolates of oxyimino-cephalosporin-resistant Gram-negative bacteria.
    Stürenburg E, Lang M, Horstkotte MA, Laufs R, Mack D.
    J Antimicrob Chemother; 2004 Nov; 54(5):870-5. PubMed ID: 15471997
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. In-vitro activity of cefpodoxime proxetil (RU 51807): a comparative disk diffusion study on isolates from geriatric patients.
    Ottomano C, Frugoni S, Berlusconi A, Miseferi G, Mattina R, Anelli M.
    J Chemother; 1991 Jan; 3 Suppl 1():62-5. PubMed ID: 12041788
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. False extended-spectrum beta-lactamase detection in Acinetobacter spp. due to intrinsic susceptibility to clavulanic acid.
    Beceiro A, Fernández-Cuenca F, Ribera A, Martínez-Martínez L, Pascual A, Vila J, Rodríguez-Baño J, Cisneros JM, Pachón J, Bou G, Spanish Group for Nosocomial Infection (GEIH).
    J Antimicrob Chemother; 2008 Feb; 61(2):301-8. PubMed ID: 18065824
    [Abstract] [Full Text] [Related]

  • 10. Susceptibility patterns for amoxicillin/clavulanate tests mimicking the licensed formulations and pharmacokinetic relationships: do the MIC obtained with 2:1 ratio testing accurately reflect activity against beta-lactamase-producing strains of Haemophilus influenzae and Moraxella catarrhalis?
    Pottumarthy S, Sader HS, Fritsche TR, Jones RN.
    Diagn Microbiol Infect Dis; 2005 Nov; 53(3):225-31. PubMed ID: 16257168
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Bacteriologic and clinical efficacy of high dose amoxicillin for therapy of acute otitis media in children.
    Piglansky L, Leibovitz E, Raiz S, Greenberg D, Press J, Leiberman A, Dagan R.
    Pediatr Infect Dis J; 2003 May; 22(5):405-13. PubMed ID: 12792379
    [Abstract] [Full Text] [Related]

  • 13. Frequency of extended spectrum beta lactamase producing gram negative bacilli among clinical isolates at clinical laboratories of Army Medical College, Rawalpindi.
    Ali AM, Rafi S, Qureshi AH.
    J Ayub Med Coll Abbottabad; 2004 May; 16(1):35-7. PubMed ID: 15125178
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Susceptibility patterns of bacterial isolates from hospitalised patients with respiratory tract infections (MOXIAKTIV Study).
    Jacobs E, Dalhoff A, Korfmann G.
    Int J Antimicrob Agents; 2009 Jan; 33(1):52-7. PubMed ID: 18835763
    [Abstract] [Full Text] [Related]

  • 16. Implications of beta-lactamase-inhibitor combinations.
    Fuchs PC, Barry AL.
    J Reprod Med; 1990 Mar; 35(3 Suppl):317-21. PubMed ID: 2319514
    [Abstract] [Full Text] [Related]

  • 17. [Resistance to newer beta-lactams and related ESBL types in gram-negative nosocomial isolates in Turkish hospitals: results of the multicentre HITIT study].
    Gür D, Gülay Z, Akan OA, Aktaş Z, Kayacan CB, Cakici O, Eraç B, Gültekin M, Oğünç D, Söyletir G, Unal N, Uysal S.
    Mikrobiyol Bul; 2008 Oct; 42(4):537-44. PubMed ID: 19149074
    [Abstract] [Full Text] [Related]

  • 18. In vitro activity of ceftaroline (PPI-0903M, T-91825) against bacteria with defined resistance mechanisms and phenotypes.
    Mushtaq S, Warner M, Ge Y, Kaniga K, Livermore DM.
    J Antimicrob Chemother; 2007 Aug; 60(2):300-11. PubMed ID: 17548456
    [Abstract] [Full Text] [Related]

  • 19. Evaluation in an animal model and in vitro of the combination clavulanic acid and cephalosporins against beta-lactamase producing and nonproducing Staphylococcus aureus strains.
    de Sá Del Fiol F, Rocha De Mattos Filho T, Groppo FC.
    Braz J Infect Dis; 2000 Feb; 4(1):36-42. PubMed ID: 10788844
    [Abstract] [Full Text] [Related]

  • 20. Emergence of extended spectrum beta lactamase mediated resistance in neonatal septicemia.
    Vinodkumar CS, Neelagund YF.
    Indian J Pathol Microbiol; 2006 Oct; 49(4):616-9. PubMed ID: 17183878
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 44.